This site is intended for healthcare professionals
News

Tepezza data from the phase II clinical trial evaluates longer-term responses in people living with thyroid eye disease (TED).- Horizon Therapeutics

Read time: 1 mins
Last updated:15th Oct 2020
Published:15th Oct 2020
Condition: Thyroid Eye Disease
Type: drug
Register free for full access to medthority.com